Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y
Clinical trial NCT00698555 · COMPLETED
Trial details
- NCT number
- NCT00698555
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1997-03-01
- Primary completion
- 1998-05-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.